119 related articles for article (PubMed ID: 37011699)
21. Overexpression of Ubiquitin-Specific Protease15 (USP15) Promotes Tumor Growth and Inhibits Apoptosis and Correlated With Poor Disease-Free Survival in Hepatocellular Carcinoma.
Yao XQ; Li L; Piao LZ; Zhang GJ; Huang XZ; Wang Y; Liang ZL
Technol Cancer Res Treat; 2020; 19():1533033820967455. PubMed ID: 33267707
[TBL] [Abstract][Full Text] [Related]
22. Ubiquitin-specific protease 1 acts as an oncogene and promotes lenvatinib efficacy in hepatocellular carcinoma by stabilizing c-kit.
Chen Z; Ma Y; Guo Z; Song D; Chen Z; Sun M
Ann Hepatol; 2022; 27(2):100669. PubMed ID: 35045360
[TBL] [Abstract][Full Text] [Related]
23. GSTZ1 sensitizes hepatocellular carcinoma cells to sorafenib-induced ferroptosis via inhibition of NRF2/GPX4 axis.
Wang Q; Bin C; Xue Q; Gao Q; Huang A; Wang K; Tang N
Cell Death Dis; 2021 Apr; 12(5):426. PubMed ID: 33931597
[TBL] [Abstract][Full Text] [Related]
24. Plumbagin promotes human hepatoma SMMC-7721 cell apoptosis via caspase-3/vimentin signal-mediated EMT.
Wei Y; Lv B; Xie J; Zhang Y; Lin Y; Wang S; Zhong J; Chen Y; Peng Y; Ma J
Drug Des Devel Ther; 2019; 13():2343-2355. PubMed ID: 31409969
[TBL] [Abstract][Full Text] [Related]
25. Targeting NQO1/GPX4-mediated ferroptosis by plumbagin suppresses in vitro and in vivo glioma growth.
Zhan S; Lu L; Pan SS; Wei XQ; Miao RR; Liu XH; Xue M; Lin XK; Xu HL
Br J Cancer; 2022 Jul; 127(2):364-376. PubMed ID: 35396498
[TBL] [Abstract][Full Text] [Related]
26. Deubiquitinating enzyme USP46 suppresses the progression of hepatocellular carcinoma by stabilizing MST1.
Qiu Y; Huang D; Sheng Y; Huang J; Li N; Zhang S; Hong Z; Yin X; Yan J
Exp Cell Res; 2021 Aug; 405(1):112646. PubMed ID: 34029571
[TBL] [Abstract][Full Text] [Related]
27. Deubiquitinase USP39 and E3 ligase TRIM26 balance the level of ZEB1 ubiquitination and thereby determine the progression of hepatocellular carcinoma.
Li X; Yuan J; Song C; Lei Y; Xu J; Zhang G; Wang W; Song G
Cell Death Differ; 2021 Aug; 28(8):2315-2332. PubMed ID: 33649471
[TBL] [Abstract][Full Text] [Related]
28. OPA1 downregulation is involved in sorafenib-induced apoptosis in hepatocellular carcinoma.
Zhao X; Tian C; Puszyk WM; Ogunwobi OO; Cao M; Wang T; Cabrera R; Nelson DR; Liu C
Lab Invest; 2013 Jan; 93(1):8-19. PubMed ID: 23108376
[TBL] [Abstract][Full Text] [Related]
29. Sigma-1 receptor protects against ferroptosis in hepatocellular carcinoma cells.
Bai T; Lei P; Zhou H; Liang R; Zhu R; Wang W; Zhou L; Sun Y
J Cell Mol Med; 2019 Nov; 23(11):7349-7359. PubMed ID: 31507082
[TBL] [Abstract][Full Text] [Related]
30. USP14 activation promotes tumor progression in hepatocellular carcinoma.
Huang G; Li L; Zhou W
Oncol Rep; 2015 Dec; 34(6):2917-24. PubMed ID: 26397990
[TBL] [Abstract][Full Text] [Related]
31. p53-dependent upregulation of miR-16-2 by sanguinarine induces cell cycle arrest and apoptosis in hepatocellular carcinoma.
Zhang B; Wang X; Deng J; Zheng H; Liu W; Chen S; Tian J; Wang F
Cancer Lett; 2019 Sep; 459():50-58. PubMed ID: 31163195
[TBL] [Abstract][Full Text] [Related]
32. Long non-coding RNA TPTEP1 inhibits hepatocellular carcinoma progression by suppressing STAT3 phosphorylation.
Ding H; Liu J; Zou R; Cheng P; Su Y
J Exp Clin Cancer Res; 2019 May; 38(1):189. PubMed ID: 31072375
[TBL] [Abstract][Full Text] [Related]
33. Tumor necrosis factor α-induced protein 1 as a novel tumor suppressor through selective downregulation of CSNK2B blocks nuclear factor-κB activation in hepatocellular carcinoma.
Xiao Y; Huang S; Qiu F; Ding X; Sun Y; Wei C; Hu X; Wei K; Long S; Xie L; Xun Y; Chen W; Zhang Z; Liu N; Xiang S
EBioMedicine; 2020 Jan; 51():102603. PubMed ID: 31901862
[TBL] [Abstract][Full Text] [Related]
34. Fbxw7 is an independent prognostic marker and induces apoptosis and growth arrest by regulating YAP abundance in hepatocellular carcinoma.
Tu K; Yang W; Li C; Zheng X; Lu Z; Guo C; Yao Y; Liu Q
Mol Cancer; 2014 May; 13():110. PubMed ID: 24884509
[TBL] [Abstract][Full Text] [Related]
35. TAK1 Is a Novel Target in Hepatocellular Carcinoma and Contributes to Sorafenib Resistance.
Xia S; Ji L; Tao L; Pan Y; Lin Z; Wan Z; Pan H; Zhao J; Cai L; Xu J; Cai X
Cell Mol Gastroenterol Hepatol; 2021; 12(3):1121-1143. PubMed ID: 33962073
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of proteasomal deubiquitinases USP14 and UCHL5 overcomes tyrosine kinase inhibitor resistance in chronic myeloid leukaemia.
Jiang L; He Q; Chen X; Liu A; Ding W; Zhang H; Chen X; Zhou H; Meng Y; Liu B; Peng G; Wang C; Liu J; Shi X
Clin Transl Med; 2022 Sep; 12(9):e1038. PubMed ID: 36082692
[TBL] [Abstract][Full Text] [Related]
37. Comprehensive analysis of ubiquitin-specific protease 1 reveals its importance in hepatocellular carcinoma.
Zhao Y; Xue C; Xie Z; Ouyang X; Li L
Cell Prolif; 2020 Oct; 53(10):e12908. PubMed ID: 32951278
[TBL] [Abstract][Full Text] [Related]
38. CRISPR screens uncover protective effect of PSTK as a regulator of chemotherapy-induced ferroptosis in hepatocellular carcinoma.
Chen Y; Li L; Lan J; Cui Y; Rao X; Zhao J; Xing T; Ju G; Song G; Lou J; Liang J
Mol Cancer; 2022 Jan; 21(1):11. PubMed ID: 34983546
[TBL] [Abstract][Full Text] [Related]
39. Broad Spectrum Deubiquitinase Inhibition Induces Both Apoptosis and Ferroptosis in Cancer Cells.
Yang L; Chen X; Yang Q; Chen J; Huang Q; Yao L; Yan D; Wu J; Zhang P; Tang D; Zhong N; Liu J
Front Oncol; 2020; 10():949. PubMed ID: 32596160
[TBL] [Abstract][Full Text] [Related]
40. Arvanil induces ferroptosis of hepatocellular carcinoma by binding to MICU1.
Deng X; Gui Y; Zhao L; Li N; Li L
Cancer Gene Ther; 2024 Jan; 31(1):148-157. PubMed ID: 37985721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
